Home/ Supplements/ Same/ Cravings

Cravings

product on market Capsule myDNAhealth Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 70% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This profile combines amino acids and antioxidants, including L-Tyrosine and NAC, which have moderate evidence for supporting cognitive function and mood regulation. Magnesium glycinate and alpha lipoic acid are well-studied for metabolic and neurological support. Overall, the evidence coverage for this specific combination is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Cravings
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
Other Combinations
Product Type
70%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

N-Acetyl L-Cysteine
150 mg
150 mg
Market median: 500.0mg (223 products) 24 studies (A:0, B:1)
Market median: 200.0mg (52 products) 12 studies (A:0, B:6)
Market median: 220.0mg (190 products)
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews
25 mg
19.2× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
Market median: 100.0mg (283 products) 144 studies (A:1, B:64)
50 mg
Market median: 100.0mg (116 products) 18 studies (A:0, B:3)
Market median: 450.0mg (390 products) 160 studies (A:0, B:63)
5.7× RDA — above typical dose 199 studies (A:1, B:55)
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions Take two capsules before lunch or dinner to reduce cravings over the following four hours, or as directed by your healthcare practitioner.

Warnings & Precautions

Caution Do not exceed recommended dose.

Keep out of reach of children.

Do not take if you have high blood pressure, prone to seizures, have a bleeding disorder or liver disease.

Consult your medical practitioner before taking these capsules if you are on medication. It is not recommended that children, pregnant or nursing women take this supplement.

It is not recommended that children, pregnant or nursing women take this supplement.

Stop taking if any side-effects occur.

Formulation Notes

Does not contain gluten, dairy or GMO.

Contains starch.

Additional Information

Intelligent health and nutrition

Reduces cravings

For weight management

Description Cravings is a natural supplement to assist with reducing cravings and improve wellbeing. Cravings helps to stabilise blood sugar levels.

Manufactured in the United Kingdom to GMP code of practice and BS:EN 9001:2000 Quality Assured Certification

Metadata

Product Details

UPC / SKU0 700461 233336
DSLD Entry Date2019-02-25
Product TypeOther Combinations
FormCapsule
DSLD ID199642
Data Updated2026-04-11
Research

Research Evidence

12
Research Sources
58
Avg Quality
8
Meta Analysis
3
Systematic Review
1
Rct
B S-adenosyl-L-methionine for alcoholic liver diseases
Meta Analysis The Cochrane database of systematic reviews 2006 PubMed
B S-adenosyl methionine (SAMe) for depression in adults
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed
B Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Still's disease
Meta Analysis Annals of the rheumatic diseases 2024 PubMed DOI
B SAMe-TT2R2 Score to Predict Time in Therapeutic Range of Vitamin K Antagonists in Asian and Non-Asian patients: A Systematic Review and Meta-analysis
Meta Analysis American journal of cardiovascular drugs : drugs, devices, and other interventions 2024 PubMed DOI
B S-Adenosylmethionine (SAMe) as an adjuvant therapy for patients with depression: An updated systematic review and meta-analysis
Meta Analysis General hospital psychiatry 2024 PubMed DOI
B S-adenosyl-L-methionine for alcoholic liver diseases
Systematic Review The Cochrane database of systematic reviews 2001 PubMed
B WITHDRAWN: S-adenosyl-L-methionine for alcoholic liver diseases
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
C S-adenosyl-L-methionine for the treatment of chronic liver disease: a systematic review and meta-analysis
Meta Analysis PloS one 2015 PubMed DOI
C S-Adenosylmethionine (SAMe) for Liver Health: A Systematic Review
Systematic Review Nutrients 2024 PubMed DOI
C SAMe-TT2R2 to Predict Clinical Outcomes and Time in Therapeutic Range in Patients on Vitamin K Antagonists: A Systematic Review and Meta-Analysis
Meta Analysis The Annals of pharmacotherapy 2024 PubMed DOI
View all evidence for Same →
Compare

Similar Products

View all Same products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.